Current standards and ongoing controversies in the management of locally advanced non-small cell lung cancer

Seminars in Oncology

Volumn 32, Issue 3 SOPEC. ISS, 2005, Pages 284-292

  West, Howard ^a   Albain, Kathy S ^b  

^a SWEDISH MEDICAL CENTER   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ETOPOSIDE; IFOSFAMIDE; MITOMYCIN; PACLITAXEL; VINBLASTINE; VINDESINE;

ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER SURGERY; CLINICAL TRIAL; HUMAN; LUNG NON SMALL CELL CANCER; NAUSEA; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; STANDARD; TREATMENT OUTCOME; VOMITING;

EID: 20644462118     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2005.02.015     Document Type: Article

References (30)

1. H.I. Pass, H.W. Pogrebniak, S.M. Steinberg Randomized trial of neoadjuvant therapy for lung cancer Interim analysis Ann Thorac Surg 53 1992 992 998
2. R. Rosell, J. Gomez-Codina, C. Camps A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer N Engl J Med 330 1994 153 158
3. J.A. Roth, F. Fosella, R. Komaki A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small cell lung cancer J Natl Cancer Inst 86 1994 673 680
4. C.F. Mountain Revisions in the International System for Staging Lung Cancer Chest 111 1997 1710 1717
5. A. Depierre, B. Milleron, D. Moro-Sibilot Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer J Clin Oncol 20 2002 247 253
6. K. Nagai, R. Tsuchiya, T. Mori A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209) J Thorac Cardiovasc Surg 125 2003 254 260
7. K.S. Albain, V.W. Rusch, J.J. Crowley Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer Mature results of Southwest Oncology Group phase II study 8805 J Clin Oncol 13 1995 1880 1892
8. M.P. MacManus, R.J. Hicks, J.P. Matthews Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer J Clin Oncol 21 2003 1285 1292
9. K.S. Albain, C.B. Scott, V.R. Rusch Phase III study of concurrent chemotherapy and full course radiotherapy (CT/RT) versus CT/RT induction followed by surgical resection for stage IIIA (pN2) non-small cell lung cancer (NSCLC) First outcome analysis of North American Intergroup trial 0139 (RTOG 93-09) Lung Cancer 41 suppl 2 2003 S4 (abstr PL-4)
10. R.O. Dillman, S.L. Seagren, K.J. Propert A Randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small cell lung cancer N Engl J Med 323 1990 940 945
11. R.O. Dillman, J. Herndon, S.L. Seagren Improved survival in stage III non-small-cell lung cancer seven-year follow-up of Cancer and Leukemia Group B (CALGB) 8433 trial J Natl Cancer Inst 88 1996 1210 1215
12. C. Schaake-Koning, W. Van den Bogaert, O. Dalesio Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer N Engl J Med 326 1992 524 530
13. W. Sause, P. Kolesar, S. Taylor Radiation Therapy Oncology Group Eastern Cooperative Oncology Group Southwest Oncology Group Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer Chest 117 2000 358 364
14. M. Saunders, S. Dische, A. Barrett Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer Mature data from the randomised multicentre trial Radiother Oncol 52 1999 137 148
15. K. Furuse, M. Fukuoka, M. Kawahara Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small cell lung cancer J Clin Oncol 17 1999 2692 2699
16. Curran WJ, Scott CB, Langer CJ,, et al. Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemo-radiation for patients with unresected stage III NSCLC: RTOG 9410. J Clin Oncol (in press)
17. R.M. Huber, M. Schmidt, M. Flentje Induction chemotherapy and following simultaneous radio/chemotherapy versus induction chemotherapy and radiotherapy alone in inoperable NSCLC (stage IIIA/IIIB) Proc Am Soc Clin Oncol 22 2003 622 (abstr 2501)
18. F. Mornex, G. Robinet, P. Thomas Sequential versus concurrent chemo-radiation (RT-CT) in locally advanced non small cell lung cancer (NSCLC) A French randomized phase III trial of GLOT-GFPC (NPC 95-01 study) Eur J Cancer 37 suppl 6 2001 S28 (abstr 93)
19. O. Zatloukal, L. Petruzelka, M. Zemanova Concurrent versus sequential radiochemotherapy with vinorelbine plus cisplatin in locally advanced non-small cell lung cancer A randomized phase II study - long term follow-up data Lung Cancer 41 suppl 2 2003 S76 (abstr 0-262)
20. C.P. Belani, W. Wang, D.H. Johnson Induction chemotherapy followed by standard thoracic radiotherapy (Std.TRT) vs. hyperfractionated accelerated radiotherapy (HART) for patients with unresectable stage III A and B non-small cell lung cancer (NSCLC) Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597) Proc Am Soc Clin Oncol 22 2003 622 (abstr 2500)
21. H. Choy Locally advanced NSCLC Recent innovations and current paradigms 2003 Presented at the American Society for Clinical Oncology Annual Meeting, Chicago, IL, May
22. E.E. Vokes, J.E. Herndon, J. Crawford Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small cell lung cancer Cancer and Leukemia Group B study 9431 J Clin Oncol 20 2002 4191 4198
23. E.E. Vokes, J.E. Herndon, M.J. Kelley Induction chemotherapy followed by concomitant chemoradiotherapy (CT/XRT) versus CT/XRT alone for regionally advanced unresectable non-small cell lung cancer (NSCLC) Initial analysis of a randomized phase III trial Proc Am Soc Clin Oncol 23 2004 616 (abstr 7005)
24. M.A. Socinski, J.G. Rosenman, J. Halle Dose-escalating conformal thoracic radiation therapy with induction and concurrent carboplatin/paclitaxel in unresectable stage IIIA/B nonsmall cell lung carcinoma Cancer 92 2001 1213 1223
25. K.S. Albain, J.J. Crowley, A.T. Turrisi Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small cell lung cancer A Southwest Oncology Group phase II study, SWOG 9019 J Clin Oncol 20 2002 3454 3460
26. D.R. Gandara, K. Chansky, K.S. Albain Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer Phase II Southwest Oncology Group study S9504 J Clin Oncol 21 2003 2004 2010
27. H. Choy, W.J. Curran, C.B. Scott Preliminary report of the locally advanced multimodality protocol (LAMP): ACR 427: A randomized phase II study of three chemo-radiation regimens with paclitaxel, carboplatin, and throacic radiation (TRT) for patients with locally advanced non-small cell lung cancer (LA-NSCLC) Proc Am Soc Clin Oncol 21 2002 291 (abstr 1160)
28. W.T. Sause, C. Scott, S. Taylor Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588 Preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer J Natl Cancer Inst 87 1995 198 205
29. D.H. Lau, J.J. Crowley, D.R. Gandara Southwest Oncology Group phase II trial of concurrent carboplatin, etoposide, and radiation for poor-risk stage III non-small-cell lung cancer J Clin Oncol 16 1998 3078 3081
30. A. Davies, D. Lau, J. Crowley Concurrent carboplatin/etoposide and radiation followed by paclitaxel consolidation for poor risk stage III non-small cell lung cancer A Southwest Oncology Group (SWOG) phase II trial (S9712) Proc Am Soc Clin Oncol 21 2002 298a (abstr 1191)